---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-073819"
form_type: "8-K"
ticker: null
cik: "0001832415"
company_name: "Better Therapeutics, Inc."
filed_at: "2024-03-21T23:59:59+00:00"
generated_at: "2026-06-04T10:22:32.339399+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Better Therapeutics receives notice of default from Hercules Capital; all loan obligations accelerated

## Summary
- Hercules Capital notified Better Therapeutics of defaults under minimum cash covenant, MAC, and insolvency clauses in Loan and Security Agreement.
- All obligations under the loan agreement are now immediately due and payable.
- Default interest rate may be applied to all amounts due, including principal, interest, and fees.
- Company had previously disclosed loan terms in March 2023 10-K and subsequent amendments.

## SEC filing metadata
- accession: 0001193125-24-073819
- form_type: 8-K
- cik: 0001832415
- company_name: Better Therapeutics, Inc.
- filed_at: 2024-03-21T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.04
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832415/000119312524073819/0001193125-24-073819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832415/000119312524073819/d808084d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-073819
- JSON: https://secwatch.observer/filing/0001193125-24-073819.json
- Plain text: https://secwatch.observer/filing/0001193125-24-073819.txt

## Key facts
- Debt Financings
  Better Therapeutics, Inc. faced acceleration on loan with Hercules Capital, Inc..
  - Instrument: loan
  - Counterparty: Hercules Capital, Inc.
  - Event: acceleration
  source text: The Hercules Notice indicates that all obligations are now immediately due and payable, and lender and agent reserve all rights and remedies provided under the Loan and Security Agreement, including the right to charge interest at the default rate on all amounts due and owing from the Company to lender and agent, including principal, interest and fees, during the continuance of any of the events of default.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524073819/0001193125-24-073819-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.